NeuroOne Medical Technologies Corporation — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-1597.6% -$3M
$-3M
Free Cash Flow↓-1819.0% -$3M
$-3M
Investing Cash Flow↓-66.9% -$16K
$-41K
Financing Cash Flow↑+129.0% +$657K
$148K
Capex↑+66.9% +$16K
$41K
Stock-Based Comp↑+5.9% +$20K
$359K
Debt Issued
—
D&A↑+0.6% +$396
$66K
SBC Allocated Expense↑+5.9% +$20K
$359K
SBC Unrecognized Cost
$727K